Nine Monthly Results Results Snapshot
Figures in Rs cr
Standalone Nine Monthly Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2024 is 35.46% vs 27.02% in Dec 2023
Standalone Net Profit
YoY Growth in nine months ended Dec 2024 is -52.89% vs 48.78% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2024 is 24.10% vs 28.28% in Dec 2023
Interest
YoY Growth in nine months ended Dec 2024 is -38.10% vs 129.09% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2024 has fallen from Dec 2023
Compare Nine Monthly Results Of Astrazeneca Phar With
Figures in Rs cr
Standalone Nine Monthly Results
Change(INR)
Change(%)
Net Sales
1,235.81
7,329.57
-6,093.76
-83.14%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,235.81
7,329.57
-6,093.76
-83.14%
Raw Material Cost
192.88
566.08
-373.20
-65.93%
Purchase of Finished goods
720.96
1,433.87
-712.91
-49.72%
(Increase) / Decrease In Stocks
-210.44
49.31
-259.75
-526.77%
Employee Cost
191.37
1,569.75
-1,378.38
-87.81%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
62.85
0.00
62.85
Other Expenses
110.59
1,645.40
-1,534.81
-93.28%
Total Expenditure (Excl Depreciation)
1,068.21
5,264.41
-4,196.20
-79.71%
Operating Profit (PBDIT) excl Other Income
167.60
2,065.16
-1,897.56
-91.88%
Other Income
24.48
270.41
-245.93
-90.95%
Operating Profit (PBDIT)
192.08
2,335.57
-2,143.49
-91.78%
Interest
0.78
207.65
-206.87
-99.62%
Exceptional Items
-91.11
61.23
-152.34
-248.80%
Gross Profit (PBDT)
100.19
2,127.92
-2,027.73
-95.29%
Depreciation
22.30
255.85
-233.55
-91.28%
Profit Before Tax
77.89
1,872.07
-1,794.18
-95.84%
Tax
20.40
369.00
-348.60
-94.47%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
57.49
1,503.07
-1,445.58
-96.18%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
61.23
-61.23
-100.00%
Net Profit
57.49
1,564.30
-1,506.81
-96.32%
Equity Capital
5.00
40.06
-35.06
-87.52%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.00
0.00
0.00
Operating Profit Margin (Excl OI)
13.56%
28.18%
0.00
-14.62%
Gross Profit Margin
8.11%
29.03%
0.00
-20.92%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 1,235.81 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 35.46% vs 27.02% in Dec 2023
Nine Monthly - Standalone Net Profit
Standalone Net Profit 57.49 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is -52.89% vs 48.78% in Dec 2023
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 167.60 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 24.10% vs 28.28% in Dec 2023
Nine Monthly - Interest
Interest 0.78 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is -38.10% vs 129.09% in Dec 2023
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.56%
in Dec 2024Figures in Rs %
YoY Growth in nine months ended Dec 2024 has fallen from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
